Whose name is on a drug package

The name on the box is a regulated statement

People read the company name on a medication package as branding. Under the drug labeling rules it is closer to a declaration.

The rule starts with a requirement. A drug or drug product in finished package form is misbranded if its label does not conspicuously bear the name and place of business of the manufacturer, packer, or distributor.

Three roles, and they are not interchangeable. Which one a company occupies determines what it may print.

The section carves out drugs dispensed under the prescription-dispensing provision of the statute, which is the pharmacy-label situation and a different rule entirely.

Eleven operations define a manufacturer

The regulation does not leave manufacturer as a commercial description. It defines it as whoever performs all of the applicable operations from a list.

The list runs to eleven items: mixing, granulating, milling, molding, lyophilizing, tableting, encapsulating, coating, sterilizing, filling sterile or aerosol drugs into dispensing containers, and, for a medical gas, fabricating the gas.

Lyophilizing is on that list, which is directly relevant to any product supplied as a freeze-dried powder. So is sterilizing, and so is filling sterile drugs into their containers.

Only the operations that apply to the product count. A product that is never tableted does not fail the definition on that item.

Performing an operation has a physical test

The regulation guards against a firm claiming an operation it merely paid for. Three conditions all have to hold.

The work is done by individuals a majority of whom are the firm's employees and who are subject to its direction and control throughout.

It is done on premises continuously owned or leased by the firm and subject to its direction and control.

And it is done on equipment continuously owned or leased by the firm. For a corporation, a parent, subsidiary or affiliate under common ownership and control counts as the same person.

What happens when nobody does everything

Modern drug production is split across firms, and the regulation accommodates that with four named routes — but each one costs a disclosure.

A firm performing more than half the applicable operations may be represented as manufacturer if it acknowledges the others by stating on the label that "Certain manufacturing operations have been performed by other firms."

A firm performing at least one operation may be represented as manufacturer if it identifies by appropriate designation everyone who performed the rest. The regulation supplies the shape of that: made by one party, filled by another, sterilized by a third.

Or the parties may be listed as joint manufacturers, qualified by a joint-manufacture phrase, with all the names printed together in the same type size and style.

The fourth route covers a firm that performs everything except operations the agency has found are commonly contracted out. Those are named: soft-gelatin encapsulating, aerosol filling, sterilizing by irradiation, lyophilizing, and ethylene oxide sterilization.

The sentence that makes a bare name a violation

One paragraph does more work than the rest of the section combined, and it is the reason all of the above matters.

The appearance of a person's name on a drug product label without qualification is a representation that the named person is the sole manufacturer of the product.

And then the consequence, stated plainly. The representation "is false and misleading, and the drug product is misbranded under section 502(a) of the act". That follows "if the person is not the manufacturer of the product in accordance with this section."

So an unqualified name is not neutral. It asserts something specific, and the assertion can be wrong.

The six phrases a distributor is given

A company that sells a drug it did not make is a distributor, and the regulation tells it exactly how to appear.

If the distributor is named on the label, the name must be qualified by one of six phrases the section lists. Manufactured for, distributed by, and manufactured by one party for another. Manufactured for one party by another, distributor followed by the name, and marketed by. The qualifying phrases may be abbreviated.

A packer gets two phrases of its own: packed by, or packaged by.

This is why those phrases appear on so much packaging. They are not legal throat-clearing; they are the regulation's prescribed way of saying we sell this, and someone else made it.

A reader can use that directly. A qualifying phrase on a package is a statement that the named company is not the manufacturer.

Who else may appear, and the trademark exception

The default is restrictive. Except as the section provides, no person other than the manufacturer, packer, or distributor may be identified on the label.

Where two or more persons appear, the label may identify which of them to contact for further information about the product.

And where a trademark appears on the label or as a mark directly on the product, the label may identify the holder or licensee of that trademark. It may also state which of the two the named person is.

That exception is worth knowing because a trademark holder is not necessarily any of the three roles. Its presence on a package says nothing about who made anything.

The address, and the address that is allowed to be wrong

The statement of place of business must include the street address, city, state and ZIP code. For a foreign manufacturer it is the street address, city, country and any applicable mailing code.

The street address may be omitted if it is shown in a current city directory or telephone directory.

Then a provision that surprises people. Say a firm manufactures, packs or distributes at a place other than its principal place of business. The label may then state the principal place of business instead of the actual site, unless that would be misleading.

So the address on a package is not necessarily where the product was made. It can lawfully be a headquarters.

The NDC is requested, not required

A separate short section settles a question people get backwards constantly.

The National Drug Code number "is requested but not required to appear on all drug labels and in all drug labeling, including the label of any prescription drug container furnished to a consumer."

Requested, not required. The absence of an NDC from a label is not by itself a labeling violation under this section.

That is a different question from whether a product has an NDC at all, which turns on registration and listing rules rather than on labeling.

And a short rule about misleading by name

One more section in this group is brief and useful. It names two ways drug labeling becomes misleading.

A false or misleading representation with respect to another drug, a device, a food or a cosmetic. Comparative claims are inside the labeling rules, not outside them.

And a multi-ingredient drug can be misleading by being designated by a name that includes or suggests the name of one or more but not all of its ingredients. That holds even though all the ingredients are named elsewhere in the labeling.

That second one is aimed squarely at a product named after its most marketable component. Listing everything on the back does not cure a name that highlights one thing.

How to read a package with this

Look for a qualifying phrase first. Manufactured for, distributed by, marketed by, packed by — each one tells you the named company did not perform the manufacturing operations.

A bare name with no qualifier is a claim to have performed all of the applicable operations from the list of eleven, on the firm's own premises and equipment, with its own people.

A line acknowledging that certain manufacturing operations were performed by other firms is a disclosure required by the rule, not a weakness. So is a made-by, filled-by, sterilized-by breakdown.

Two limits. This section does not apply to biological drug products subject to the licensing provision of the Public Health Service Act. And it does not apply to a drug dispensed under a prescription, which carries a different label under a different rule.

Sources

Each document below is named as it names itself, with the date printed on that document rather than the day it was read.

1. 21 CFR 201.1, Drugs; name and place of business of manufacturer, packer, or distributor — Electronic Code of Federal Regulations, title 21, June 2024
2. 21 CFR 201.2, Drugs and devices; National Drug Code numbers — Electronic Code of Federal Regulations, title 21, August 2016
3. 21 CFR 201.6, Drugs; misleading statements — Electronic Code of Federal Regulations, title 21, February 1976